Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina ...
In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...
Young men, you have more control than you think. You don’t need to be rich or famous or genetically gifted. You just need to ...
It’s well-known that women are more likely to suffer from depression than men. A new study has now revealed that the genetic ...
The Wyoming Grants Management Office has confirmed that a 90-minute webinar focused on wildfire recovery will take place as planned on Oct. 8 at 10 a.m., despite the government shutdown.
About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...
The MCO-010 vector uses surviving cells in the retina to produce a photosensitive protein that may help patients regain some ...
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and ...
Dyne will also present encore data on zeleciment rostudirsen (z-rostudirsen, formerly known as DYNE-251, aninvestigational medicine being evaluated for the treatment of individuals with DMD mutations ...
Title: Integrative discovery of a multimodal cancer immunotherapy using machine learning and viral vector engineering Presenter : Anne Diers, Ph.D., Vice President, Research, Candel Therapeutics ...
From seafood gumbo to hojicha tres leches, here are some of the best things our reporters ate across Los Angeles, Orange ...
Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback